Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ImmuCell Corporation - Common Stock (NQ:ICCC)

5.074 -0.066 (-1.29%)
Streaming Delayed Price Updated: 2:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,093
Open 5.210
Bid (Size) 5.080 (7)
Ask (Size) 5.260 (3)
Prev. Close 5.140
Today's Range 5.074 - 5.250
52wk Range 3.340 - 5.820
Shares Outstanding 7,741,864
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga

Performance

YTD
-2.8%
-2.8%
1 Month
+5.5%
+5.5%
3 Month
-5.3%
-5.3%
6 Month
+43.7%
+43.7%
1 Year
-3.4%
-3.4%

More News

Read More
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Top Stock Reports For Apple, Eli Lilly & Shopify
Via Talk Markets
Topics Stocks / Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024
Via InvestorPlace
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024
Via InvestorPlace
Earnings Scheduled For February 27, 2024
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Earnings Scheduled For November 21, 2022
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Via Benzinga
Exposures Product Safety
Earnings Scheduled For November 15, 2021
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is ImmuCell Corporation - Common Stock publicly traded?
Yes, ImmuCell Corporation - Common Stock is publicly traded.
What exchange does ImmuCell Corporation - Common Stock trade on?
ImmuCell Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmuCell Corporation - Common Stock?
The ticker symbol for ImmuCell Corporation - Common Stock is ICCC on the Nasdaq Stock Market
What is the current price of ImmuCell Corporation - Common Stock?
The current price of ImmuCell Corporation - Common Stock is 5.074
When was ImmuCell Corporation - Common Stock last traded?
The last trade of ImmuCell Corporation - Common Stock was at 05/09/25 02:00 PM ET
What is the market capitalization of ImmuCell Corporation - Common Stock?
The market capitalization of ImmuCell Corporation - Common Stock is 39.28M
How many shares of ImmuCell Corporation - Common Stock are outstanding?
ImmuCell Corporation - Common Stock has 39M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.